Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 14 9 2019
Statut: ppublish

Résumé

Polymyxin B is an antibiotic that shows strong bactericidal activity against Gram-negative bacteria, by binding to and inactivating endotoxin. Systemic administration of polymyxin B in humans is restricted because of its nephrotoxicity and neurotoxicity, and this compound was therefore considered a strong candidate ligand for the extracorporeal selective adsorption of circulating endotoxin in the blood. Toraymyxin® is a direct hemoperfusion column that uses polymyxin B attached to an insoluble carrier to bind endotoxin in the blood. In 1994, the Japanese National Health Insurance system approved the use of Toraymyxin for the treatment of endotoxemia and septic shock.In this chapter, we will review the development, clinical use, and efficacy of Toraymyxin, examine the structure of the Toraymyxin column, and comment on the current position of Toraymyxin in the treatment of severe sepsis and septic shock. We will also highlight some potential new applications of Toraymyxin for pulmonary diseases.

Identifiants

pubmed: 31364085
doi: 10.1007/978-3-030-16373-0_19
pmc: PMC7123644
doi:

Substances chimiques

Anti-Bacterial Agents 0
Endotoxins 0
Polymyxin B J2VZ07J96K

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-341

Références

Anal Biochem. 2008 Feb 15;373(2):281-6
pubmed: 17980693
Intern Med. 2012;51(12):1487-91
pubmed: 22728479
J Clin Apher. 2002;17(2):97-102
pubmed: 12210714
J Biochem Biophys Methods. 2001 Oct 30;49(1-3):665-81
pubmed: 11694310
ASAIO J. 2007 May-Jun;53(3):324-8
pubmed: 17515723
J Clin Apher. 2010;25(6):350-3
pubmed: 20623785
Pediatr Res. 1979 Jan;13(1):48-51
pubmed: 219410
Intensive Care Med. 2015 Jun;41(6):975-84
pubmed: 25862039
Crit Care Med. 2001 Jul;29(7 Suppl):S13-5
pubmed: 11445727
Surg Gynecol Obstet. 1989 Apr;168(4):323-31
pubmed: 2538938
Blood Purif. 2014;37 Suppl 1:14-7
pubmed: 24457490
Intensive Care Med. 2000;26 Suppl 1:S51-6
pubmed: 10786959
Ther Apher Dial. 2005 Apr;9(2):128-36
pubmed: 15828924
Artif Organs. 1993 Sep;17(9):775-81
pubmed: 8240070
Immunochemistry. 1976 Oct;13(10):813-8
pubmed: 187544
Am J Surg. 1994 Apr;167(4):412-7
pubmed: 8179086
J Immunol Methods. 1998 Mar 15;212(2):169-85
pubmed: 9672205
Shock. 2005 May;23(5):400-5
pubmed: 15834304
Am J Dig Dis. 1972 Feb;17(2):161-6
pubmed: 4552124
J Bacteriol. 1966 Nov;92(5):1493-509
pubmed: 4288609
Am J Surg. 2004 Aug;188(2):150-6
pubmed: 15249240
Blood Purif. 2011;32(4):310-6
pubmed: 21893977
Intern Med. 2011;50(6):601-5
pubmed: 21422686
Ther Apher Dial. 2003 Feb;7(1):108-14
pubmed: 12921125
Br J Surg. 1980 Aug;67(8):565-7
pubmed: 6253004
Crit Care. 2007;11(2):R47
pubmed: 17448226
J Infect Dis. 1987 Apr;155(4):690-5
pubmed: 3029243
Ther Apher. 2002 Jun;6(3):234-40
pubmed: 12109950
Contrib Nephrol. 2010;167:45-54
pubmed: 20519898
Contrib Nephrol. 2010;167:83-90
pubmed: 20519902
Ther Apher Dial. 2011 Aug;15(4):349-54
pubmed: 21884468
Adv Exp Med Biol. 1990;256:653-64
pubmed: 2183569
Ther Apher Dial. 2015 Aug;19(4):316-23
pubmed: 26386218
J Infect Dis. 1987 Nov;156(5):706-12
pubmed: 2821123
Prog Clin Biol Res. 1988;264:337-41
pubmed: 2837785
Pediatr Int. 2016 May;58(5):411-414
pubmed: 26710929
Am J Med Sci. 2007 Oct;334(4):244-7
pubmed: 18030179
Pediatr Int. 2016 Mar;58(3):237-40
pubmed: 26669790
Shock. 2009 Nov;32(5):478-83
pubmed: 19295483
Blood Purif. 2014;37 Suppl 1:22-5
pubmed: 24457492
Intern Med. 2006;45(18):1033-8
pubmed: 17043373
Transfus Apher Sci. 2013 Dec;49(3):499-503
pubmed: 23683501
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1768-73
pubmed: 11734424
J Bacteriol. 1969 Nov;100(2):1128-9
pubmed: 4311679
J Endotoxin Res. 2004;10(4):229-37
pubmed: 15373966
Z Naturforsch C. 1973 Jul-Aug;28(7):422-30
pubmed: 4358580
FEBS Lett. 2000 Mar 24;470(2):151-5
pubmed: 10734225
FASEB J. 1998 Aug;12(11):1035-44
pubmed: 9707176
Pediatr Res. 2005 Aug;58(2):309-14
pubmed: 16006426
ASAIO J. 2008 Jan-Feb;54(1):129-32
pubmed: 18204329
J Surg Res. 2011 Nov;171(1):183-90
pubmed: 20338589
Ther Apher Dial. 2006 Feb;10(1):7-11
pubmed: 16556130
Respir Investig. 2012 Dec;50(4):140-50
pubmed: 23199978
Artif Organs. 1998 Dec;22(12):1038-44
pubmed: 9876096
Shock. 2013 Dec;40(6):504-11
pubmed: 24089007
Ther Apher. 1998 Feb;2(1):3-12
pubmed: 10227782
Surgery. 2013 Feb;153(2):262-71
pubmed: 22884251
J Surg Res. 2001 Sep;100(1):127-34
pubmed: 11516215
Blood Purif. 2001;19(4):361-8; discussion 368-9
pubmed: 11574732
Biomater Artif Cells Artif Organs. 1990;18(4):491-7
pubmed: 2285811
Contrib Nephrol. 2010;167:77-82
pubmed: 20519901
Blood Purif. 2015;39(1-3):I-II
pubmed: 25998615
JAMA. 2009 Jun 17;301(23):2445-52
pubmed: 19531784
Crit Care. 2012 Aug 07;16(4):R148
pubmed: 22871090
Clin Chem Lab Med. 1999 Mar;37(3):373-9
pubmed: 10353486
Langenbecks Arch Surg. 2009 Mar;394(2):303-11
pubmed: 18685861

Auteurs

Tohru Tani (T)

Biomedical Innovation Center, Shiga University of Medical Science, Otsu, Shiga, Japan. tan@belle.shiga-med.ac.jp.
Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan. tan@belle.shiga-med.ac.jp.

Tomoharu Shimizu (T)

Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.

Masaji Tani (M)

Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.

Hisataka Shoji (H)

Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.

Yoshihiro Endo (Y)

Department of Clinical Nursing, Shiga University of Medical Science, Otsu, Shiga, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH